The IC50 of the LB100 protein target, protein phosphatase 2A (PP2A), in glial cell lines is between 0.2– 0.4 uM; therefore, the drug levels in tumor tissue did not achieve a concentration that would be expected to result in a biological response(11–13). Here, PTPA is linked to neoplasm.